{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:49:22Z","timestamp":1774079362349,"version":"3.50.1"},"reference-count":87,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Blood platelets are derived from megakaryocytes with functions extending beyond hemostasis to inflammation, immunity, and cancer. Myeloproliferative neoplasms (MPNs) are clonal stem cell disorders driven by somatic mutations affecting JAK-STAT signaling, leading to excessive myeloid proliferation. Thrombosis affects approximately one-fifth of patients at diagnosis and remains elevated throughout the disease course, while the paradoxical coexistence of bleeding further complicates clinical management. In addition, MPNs may progress to advanced disease stages, including bone marrow fibrosis and transformation to acute myeloid leukemia, leading to ineffective hematopoiesis, worsening symptom burden, and poor clinical outcomes. This review outlines how peripherally circulating platelets provide a unique window into MPN pathophysiology, with emphasis on their functional and molecular abnormalities. We summarize current understanding of platelet-mediated hemostatic imbalance across MPN subtypes. We discuss the potential of platelet transcriptomics and proteomics to reveal disease-specific signatures. We further highlight emerging platelet-associated candidates with potential utility as dynamic biomarkers for both the pathological marrow niche and thrombotic and bleeding risk. Together, these insights underscore the potential of platelet-based approaches to complement existing diagnostic and prognostic strategies in MPNs.<\/jats:p>","DOI":"10.3390\/cells15060555","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:38:01Z","timestamp":1773934681000},"page":"555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular and Functional Platelet Abnormalities in Myeloproliferative Neoplasms"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4543-1646","authenticated-orcid":false,"given":"Ann X.","family":"Wang","sequence":"first","affiliation":[{"name":"School of Biomedical Science, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-8561","authenticated-orcid":false,"given":"Belinda B.","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Biomedical Science, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9126-2166","authenticated-orcid":false,"given":"Matthew D.","family":"Linden","sequence":"additional","affiliation":[{"name":"School of Biomedical Science, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, L., Wang, X., Guo, E., Mao, X., and Miao, S. (2022). Emerging roles of platelets in cancer biology and their potential as therapeutic targets. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.939089"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hoc.2020.12.001","article-title":"Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications","volume":"35","author":"Tremblay","year":"2021","journal-title":"Hematol.\/Oncol. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: Document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for Arterial and Venous Thrombosis in Patients with Myeloproliferative Neoplasms: A Population-Based Cohort Study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41408-024-01169-6","article-title":"Thrombosis in myeloproliferative neoplasms: A viewpoint on its impact on myelofibrosis, mortality, and solid tumors","volume":"14","author":"Barbui","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: A literature review of incidence and risk factors","volume":"5","author":"Cerquozzi","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ijlh.14086","article-title":"Morphology of myeloproliferative neoplasms","volume":"45","author":"Ng","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/ATVBAHA.121.316373","article-title":"Platelet Heterogeneity in Myeloproliferative Neoplasms","volume":"41","author":"Thomas","year":"2021","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.rpth.2023.100060","article-title":"Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2 (V617F) mutation","volume":"7","author":"Guy","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Varricchio, L., and Hoffman, R. (2022). Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.906698"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ajpath.2017.03.009","article-title":"Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations","volume":"187","author":"Guo","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"De Wispelaere, K., and Freson, K. (2022). The Analysis of the Human Megakaryocyte and Platelet Coding Transcriptome in Healthy and Diseased Subjects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147647"},{"key":"ref_16","unstructured":"Passos, G.A. (2022). The Interplay Between the Transcriptomics and Proteomics Profiles. Transcriptomics in Health and Disease, Springer International Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymeth.2023.10.003","article-title":"PlateletSeq: A novel method for discovery of blood-based biomarkers","volume":"219","author":"Collinson","year":"2023","journal-title":"Methods"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: From megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1538-7836.2009.03419.x","article-title":"Molecular mechanisms of thrombopoietin signaling","volume":"7","author":"Kaushansky","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2017.10.001","article-title":"Megakaryocyte and polyploidization","volume":"57","author":"Mazzi","year":"2018","journal-title":"Exp. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.119.313280","article-title":"Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease","volume":"40","author":"Rowley","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Song, X., and Song, X. (2023). Contents in tumor-educated platelets as the novel biosource for cancer diagnostics. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1165600"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/blood.2019003976","article-title":"Lessons to learn from tumor-educated platelets","volume":"137","author":"Roweth","year":"2021","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Kralovics","year":"2023","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-18-4089","article-title":"Activation of JAK\/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo","volume":"25","author":"Woods","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ma, X., Zhou, Z., Gu, S., Guo, Y., Zhou, T., Shao, R., Yan, J., Chen, W., and Shi, X. (2025). Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs). Cancers, 17.","DOI":"10.3390\/cancers17193142"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/stem.2888","article-title":"JAK2V617F Megakaryocytes Promote Hematopoietic Stem\/Progenitor Cell Expansion in Mice Through Thrombopoietin\/MPL Signaling","volume":"36","author":"Zhang","year":"2018","journal-title":"Stem Cells"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Balduini, A., Badalucco, S., Pugliano, M.T., Baev, D., De Silvestri, A., Cattaneo, M., Rosti, V., and Barosi, G. (2011). In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: Distinct patterns in the different clinical phenotypes. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021015"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.leukres.2010.03.040","article-title":"Aberrant proplatelet formation in chronic myeloproliferative neoplasms","volume":"34","author":"Muth","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/ehm.09.75","article-title":"Akt signaling in platelets and thrombosis","volume":"3","author":"Woulfe","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2010-12-323204","article-title":"An important role for Akt3 in platelet activation and thrombosis","volume":"118","author":"Hay","year":"2011","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbior.2015.06.001","article-title":"PI3K\/Akt in platelet integrin signaling and implications in thrombosis","volume":"59","author":"Guidetti","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/jth.14967","article-title":"Platelet MAPKs-a 20+ year history: What do we really know?","volume":"18","author":"Patel","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Baumeister, J., Chatain, N., Sofias, A.M., Lammers, T., and Koschmieder, S. (2021). Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives. Cells, 10.","DOI":"10.3390\/cells10123551"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.2022017423","article-title":"Myelofibrosis","volume":"141","author":"Passamonti","year":"2023","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.5045\/br.2023.2023038","article-title":"Prognostication in myeloproliferative neoplasms, including mutational abnormalities","volume":"58","author":"Hong","year":"2023","journal-title":"Blood Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.19164","article-title":"Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline","volume":"204","author":"McLornan","year":"2024","journal-title":"Br. J. Haematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.2024025627","article-title":"How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms","volume":"145","author":"Guy","year":"2025","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.tru.2021.100081","article-title":"Thrombosis in myeloproliferative neoplasms: A clinical and pathophysiological perspective","volume":"5","author":"Kelliher","year":"2021","journal-title":"Thromb. Update"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","article-title":"Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms","volume":"129","author":"Rumi","year":"2017","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e172256","DOI":"10.1172\/JCI172256","article-title":"Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms","volume":"134","author":"He","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109559","DOI":"10.1016\/j.thromres.2025.109559","article-title":"Platelets display immunophenotypic alterations and dysregulated transcriptomic signature in Philadelphia-negative myeloproliferative neoplasms","volume":"257","author":"Bassan","year":"2026","journal-title":"Thromb. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/ijlh.13754","article-title":"Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms","volume":"44","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/09537104.2021.1934665","article-title":"Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function","volume":"33","author":"Melrose","year":"2022","journal-title":"Platelets"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1002\/jha2.70000","article-title":"Treatment of Myeloproliferative Neoplasms with Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety","volume":"6","author":"Dunn","year":"2025","journal-title":"eJHaem"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Marin Oyarz\u00fan, C.P., and Heller, P.G. (2019). Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01373"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10760296221097969","DOI":"10.1177\/10760296221097969","article-title":"Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms","volume":"28","author":"Papageorgiou","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rungjirajittranon, T., Owattanapanich, W., Ungprasert, P., Siritanaratkul, N., and Ruchutrakool, T. (2019). A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5387-9"},{"key":"ref_52","first-page":"e56008","article-title":"A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients with Myeloproliferative Neoplasms Scheduled for Surgery","volume":"16","author":"Andreescu","year":"2024","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11899-017-0400-3","article-title":"Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis","volume":"12","author":"Martin","year":"2017","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bjh.18322","article-title":"Practical management of the haemorrhagic complications of myeloproliferative neoplasms","volume":"199","author":"Jones","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1038\/s41598-023-36266-2","article-title":"Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin","volume":"13","author":"Ross","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100433","DOI":"10.1016\/j.xcrm.2021.100433","article-title":"Message in a platelet: Decoding platelet transcriptomes in myeloproliferative neoplasms","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100425","DOI":"10.1016\/j.xcrm.2021.100425","article-title":"Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms","volume":"2","author":"Shen","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.hoc.2020.11.003","article-title":"The Microenvironment in Myeloproliferative Neoplasms","volume":"35","author":"Ramanathan","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjh.16152","article-title":"Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis","volume":"188","author":"Guo","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41408-024-01146-z","article-title":"Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma","volume":"14","author":"Montaner","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"106920","DOI":"10.1016\/j.leukres.2022.106920","article-title":"Targeting cyclin-dependent kinases 4\/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia","volume":"120","author":"Qi","year":"2022","journal-title":"Leuk. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: A sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/bloodadvances.2025017375","article-title":"Induction of moderate DNA damage enhances megakaryopoiesis and platelet production","volume":"10","author":"Camacho","year":"2026","journal-title":"Blood Adv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/onc.2015.128","article-title":"Beyond cytokinesis: The emerging roles of CEP55 in tumorigenesis","volume":"35","author":"Jeffery","year":"2016","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"28279","DOI":"10.1038\/s41598-024-80057-2","article-title":"Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinoma","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood-2024-207499","article-title":"Priming of Megakaryopoiesis and Platelet Production through DNA Damage Repair Inhibition","volume":"144","author":"Bekendam","year":"2024","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"qiaf093","DOI":"10.1093\/jleuko\/qiaf093","article-title":"Megakaryocyte emperipolesis in myeloproliferative neoplasms: Are neutrophils friends or foes?","volume":"117","author":"Collinson","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chebbo, M., Assou, S., Pantesco, V., Duez, C., Alessi, M.C., Chanez, P., and Gras, D. (2022). Platelets Purification Is a Crucial Step for Transcriptomic Analysis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063100"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.jtha.2024.06.017","article-title":"Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: Communication from the SSC of the ISTH","volume":"22","author":"Banerjee","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jth.13302","article-title":"Platelet signaling: A complex interplay between inhibitory and activatory networks","volume":"14","author":"Bye","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"104060","DOI":"10.1016\/j.transci.2024.104060","article-title":"Platelet proteomics: Clinical implications\u2014Decoding the black box!","volume":"64","author":"Goubran","year":"2025","journal-title":"Transfus. Apher. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/bloodadvances.2023012016","article-title":"Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms","volume":"8","author":"Kelliher","year":"2024","journal-title":"Blood Adv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"102396","DOI":"10.1016\/j.bcmd.2019.102396","article-title":"Higher AURKA and PLK1 expression are associated with inferior overall survival in patients with myelofibrosis","volume":"81","author":"Galusic","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3995","article-title":"Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition","volume":"21","author":"Wen","year":"2015","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/1078-0432.CCR-19-1005","article-title":"Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial","volume":"25","author":"Gangat","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_76","first-page":"85","article-title":"Platelets and galectins","volume":"2","author":"Schattner","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"eadj7552","DOI":"10.1126\/scitranslmed.adj7552","article-title":"A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis","volume":"16","author":"Li","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"De Almeida, S., Regimbeau, M., Jego, G., Garrido, C., Girodon, F., and Hermetet, F. (2020). Heat Shock Proteins and PD-1\/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms. Cancers, 12.","DOI":"10.3390\/cancers12092592"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jth.13998","article-title":"The chaperone protein HSP47: A platelet collagen binding protein that contributes to thrombosis and hemostasis","volume":"16","author":"Sasikumar","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"102177","DOI":"10.1016\/j.rpth.2023.102177","article-title":"Role of heat shock protein 47 in platelet glycoprotein VI dimerization and signaling","volume":"7","author":"AlOuda","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2006.12.001","article-title":"The collagen-specific molecular chaperone HSP47: Is there a role in fibrosis?","volume":"13","author":"Taguchi","year":"2007","journal-title":"Trends Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kraemer, B.F., Mannell, H., Lamkemeyer, T., Franz-Wachtel, M., and Lindemann, S. (2019). Heat-Shock Protein 27 (HSPB1) Is Upregulated and Phosphorylated in Human Platelets during ST-Elevation Myocardial Infarction. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235968"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tokuda, H., Kuroyanagi, G., Tsujimoto, M., Enomoto, Y., Matsushima-Nishiwaki, R., Onuma, T., Kojima, A., Doi, T., Tanabe, K., and Akamatsu, S. (2015). Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128977"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jego, G., Hermetet, F., Girodon, F., and Garrido, C. (2019). Chaperoning STAT3\/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy. Cancers, 12.","DOI":"10.3390\/cancers12010021"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bj3160093","article-title":"Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation","volume":"316","author":"Watson","year":"1996","journal-title":"Biochem. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood.V87.2.439.bloodjournal872439","article-title":"Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets","volume":"87","author":"Miyakawa","year":"1996","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"24386","DOI":"10.1074\/jbc.M501174200","article-title":"Thrombopoietin Complements Gi- but Not Gq-dependent Pathways for Integrin \u03b1IIb\u03b23 Activation and Platelet Aggregation","volume":"280","author":"Campus","year":"2005","journal-title":"J. Biol. Chem."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/6\/555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:19:38Z","timestamp":1774070378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/6\/555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":87,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cells15060555"],"URL":"https:\/\/doi.org\/10.3390\/cells15060555","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}